<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(41)</volume><submitter>Han Z</submitter><pubmed_abstract>An efficient organocatalytic conjugated addition reaction of pyrazol-3-ones with 3-trifluoroethylidene oxindoles has been developed for the synthesis of enantioenriched triflouromethylated indolin-2-ones bearing adjacent tertiary chiral centers in good yields and good to excellent diastereo- and enantioselectivities. The use of a newly developed chiral spirobiindane-derived squaramide catalyst is essential in achieving high diastereo- and enantioselectivities.</pubmed_abstract><journal>RSC advances</journal><pagination>27012-27021</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9490773</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Organocatalytic diastereo- and enantioselective conjugate addition of pyrazol-3-ones to 3-trifluoroethylidene oxindoles with a newly developed squaramide catalyst.</pubmed_title><pmcid>PMC9490773</pmcid><pubmed_authors>Woldegiorgis AG</pubmed_authors><pubmed_authors>Lin X</pubmed_authors><pubmed_authors>Han Z</pubmed_authors><pubmed_authors>Jin J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Organocatalytic diastereo- and enantioselective conjugate addition of pyrazol-3-ones to 3-trifluoroethylidene oxindoles with a newly developed squaramide catalyst.</name><description>An efficient organocatalytic conjugated addition reaction of pyrazol-3-ones with 3-trifluoroethylidene oxindoles has been developed for the synthesis of enantioenriched triflouromethylated indolin-2-ones bearing adjacent tertiary chiral centers in good yields and good to excellent diastereo- and enantioselectivities. The use of a newly developed chiral spirobiindane-derived squaramide catalyst is essential in achieving high diastereo- and enantioselectivities.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-05T13:27:45.613Z</modification><creation>2025-04-05T13:27:45.613Z</creation></dates><accession>S-EPMC9490773</accession><cross_references><pubmed>36320851</pubmed><doi>10.1039/d2ra05088a</doi></cross_references></HashMap>